TORONTO, Dec. 1 /PRNewswire-FirstCall/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH, NASDAQ: TTHI) today announced the dates for the following upcoming corporate events:
20th Annual Piper Jaffray Health Care Conference
Transition will present at the upcoming 20th Annual Piper Jaffray Health Care Conference. The presentation will take place on Tuesday, December 2nd, 2008 at 12:30 P.M. (Eastern Time) at the New York Palace.
2008 Annual General Meeting of Shareholders
Transition's Annual General Meeting will occur Monday, December 8, 2008 at the MaRS Centre, South Tower, 101 College Street, Main Floor, Room CR-3, Toronto, Ontario at 4:00 P.M. (Eastern Time).
2008 Healthcare Conference hosted by RBC Capital Markets
Dr. Tony Cruz, Chairman and Chief Executive Officer of Transition, will participate in the upcoming 2008 Healthcare Conference hosted by RBC Capital Markets. Dr. Cruz is scheduled to participate in a panel session titled "The Challenge of Alzheimer's Disease" on Thursday, December 11th, 2008 between 12:30 - 1:25 P.M. (Eastern Time) at the Westin Times Square New York. A live webcast and archived version of this event will be available on the Transition website www.transitiontherapeutics.com.
About Transition
----------------
Transition is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets. Transition's lead products include ELND005 (AZD-103) for the treatment of Alzheimer's disease and TT-223 for the treatment of diabetes. Transition has an emerging pipeline of preclinical drug candidates acquired externally and developed internally using
'/>"/>
| SOURCE Transition Therapeutics Inc. Copyright©2008 PR Newswire. All rights reserved |